Cargando…
Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis
BACKGROUND: Palliative shunts in congenital heart disease patients are vulnerable to thrombotic occlusion. High mechanical index (MI) impulses from a modified diagnostic ultrasound (US) transducer during a systemic microbubble (MB) infusion have been used to dissolve intravascular thrombi without an...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959668/ https://www.ncbi.nlm.nih.gov/pubmed/24518555 http://dx.doi.org/10.1161/JAHA.113.000689 |
_version_ | 1782308074242965504 |
---|---|
author | Kutty, Shelby Wu, Juefei Hammel, James M. Abraham, Joseph R. Venkataraman, Jeeva Abdullah, Ibrahim Danford, David A. Radio, Stanley J. Lof, John Porter, Thomas R. |
author_facet | Kutty, Shelby Wu, Juefei Hammel, James M. Abraham, Joseph R. Venkataraman, Jeeva Abdullah, Ibrahim Danford, David A. Radio, Stanley J. Lof, John Porter, Thomas R. |
author_sort | Kutty, Shelby |
collection | PubMed |
description | BACKGROUND: Palliative shunts in congenital heart disease patients are vulnerable to thrombotic occlusion. High mechanical index (MI) impulses from a modified diagnostic ultrasound (US) transducer during a systemic microbubble (MB) infusion have been used to dissolve intravascular thrombi without anticoagulation, and we sought to determine whether this technique could be used prophylactically to reduce thrombus burden and prevent occlusion of surgically placed extracardiac shunts. METHODS AND RESULTS: Heparin‐bonded ePTFE tubular vascular shunts of 4 mm×2.5 cm (Propaten; W.L Gore) were surgically placed in 18 pigs: a right‐sided side‐to‐side arteriovenous (AV, carotid‐jugular) shunt, and a left‐sided arterio‐arterial (AA, carotid‐carotid) interposition shunt in each animal. After shunt implantation, animals were randomly assigned to one of 3 groups. Transcutaneous, weekly 30‐minute treatments (total of 4 treatments) of either guided high MI US+MB (Group 1; n=6) using a 3% MRX‐801 MB infusion, or US alone (Group 2; n=6) were given separately to each shunt. The third group of 6 pigs received no treatments. The shunts were explanted after 4 weeks and analyzed by histopathology to quantify luminal thrombus area (mm(2)) for the length of each shunt. No pigs received antiplatelet agents or anticoagulants during the treatment period. The median overall thrombus burden in the 3 groups for AV shunts was 5.10 mm(2) compared with 4.05 mm(2) in AA (P=0.199). Group 1 pigs had significantly less thrombus burden in the AV shunts (median 2.5 mm(2)) compared with Group 2 (median 5.6 mm(2)) and Group 3 (median 7.5 mm(2)) pigs (P=0.006). No difference in thrombus burden was seen between groups for AA shunts. CONCLUSION: Transcutaneous US with intravenous MB is capable of preventing thrombus accumulation in arteriovenous shunts without the need for antiplatelet agents, and may be a method of preventing progressive occlusion of palliative shunts. |
format | Online Article Text |
id | pubmed-3959668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-39596682014-03-20 Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis Kutty, Shelby Wu, Juefei Hammel, James M. Abraham, Joseph R. Venkataraman, Jeeva Abdullah, Ibrahim Danford, David A. Radio, Stanley J. Lof, John Porter, Thomas R. J Am Heart Assoc Original Research BACKGROUND: Palliative shunts in congenital heart disease patients are vulnerable to thrombotic occlusion. High mechanical index (MI) impulses from a modified diagnostic ultrasound (US) transducer during a systemic microbubble (MB) infusion have been used to dissolve intravascular thrombi without anticoagulation, and we sought to determine whether this technique could be used prophylactically to reduce thrombus burden and prevent occlusion of surgically placed extracardiac shunts. METHODS AND RESULTS: Heparin‐bonded ePTFE tubular vascular shunts of 4 mm×2.5 cm (Propaten; W.L Gore) were surgically placed in 18 pigs: a right‐sided side‐to‐side arteriovenous (AV, carotid‐jugular) shunt, and a left‐sided arterio‐arterial (AA, carotid‐carotid) interposition shunt in each animal. After shunt implantation, animals were randomly assigned to one of 3 groups. Transcutaneous, weekly 30‐minute treatments (total of 4 treatments) of either guided high MI US+MB (Group 1; n=6) using a 3% MRX‐801 MB infusion, or US alone (Group 2; n=6) were given separately to each shunt. The third group of 6 pigs received no treatments. The shunts were explanted after 4 weeks and analyzed by histopathology to quantify luminal thrombus area (mm(2)) for the length of each shunt. No pigs received antiplatelet agents or anticoagulants during the treatment period. The median overall thrombus burden in the 3 groups for AV shunts was 5.10 mm(2) compared with 4.05 mm(2) in AA (P=0.199). Group 1 pigs had significantly less thrombus burden in the AV shunts (median 2.5 mm(2)) compared with Group 2 (median 5.6 mm(2)) and Group 3 (median 7.5 mm(2)) pigs (P=0.006). No difference in thrombus burden was seen between groups for AA shunts. CONCLUSION: Transcutaneous US with intravenous MB is capable of preventing thrombus accumulation in arteriovenous shunts without the need for antiplatelet agents, and may be a method of preventing progressive occlusion of palliative shunts. Blackwell Publishing Ltd 2014-02-28 /pmc/articles/PMC3959668/ /pubmed/24518555 http://dx.doi.org/10.1161/JAHA.113.000689 Text en © 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Kutty, Shelby Wu, Juefei Hammel, James M. Abraham, Joseph R. Venkataraman, Jeeva Abdullah, Ibrahim Danford, David A. Radio, Stanley J. Lof, John Porter, Thomas R. Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis |
title | Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis |
title_full | Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis |
title_fullStr | Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis |
title_full_unstemmed | Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis |
title_short | Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis |
title_sort | prevention of arteriovenous shunt occlusion using microbubble and ultrasound mediated thromboprophylaxis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959668/ https://www.ncbi.nlm.nih.gov/pubmed/24518555 http://dx.doi.org/10.1161/JAHA.113.000689 |
work_keys_str_mv | AT kuttyshelby preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis AT wujuefei preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis AT hammeljamesm preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis AT abrahamjosephr preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis AT venkataramanjeeva preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis AT abdullahibrahim preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis AT danforddavida preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis AT radiostanleyj preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis AT lofjohn preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis AT porterthomasr preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis |